Exact Mass: 572.2123
Exact Mass Matches: 572.2123
Found 100 metabolites which its exact mass value is equals to given mass value 572.2123
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
chiglitazar
Letermovir
4-[(2-{Bis[(pyridin-2-YL)methyl]amino}ethyl)amino]-2-(6-hydroxy-3-oxo-3H-xanthen-9-YL)benzoic acid
3-(3-Hydroxy-2,4-dimethoxyphenyl)-4-[5-(7-hydroxy-3,4-dihydro-2H-1-benzopyran-3-yl)-4-hydroxy-2-methoxyphenyl]-7-hydroxy-3,4-dihydro-2H-1-benzopyran
15-O-beta-D-glucipyranosyl-21-hydroxyglaucarubolone
(S)-7-O-methylpeucedanol 3-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside
5-Methoxy-(3R,4S,3S)-4-(6,7-Dihydroxy-4-methoxyisoflavan-3-yl)-2,7-dihydroxy-4-methoxyisoflavan
3-(2-Hydroxy-4,5-dimethoxyphenyl)-4-[5-(7-hydroxy-3,4-dihydro-2H-1-benzopyran-3-yl)-4-hydroxy-2-methoxyphenyl]-7-hydroxy-3,4-dihydro-2H-1-benzopyran
3-Hydroxy,2-Me ether-(3R,4S,3S)-4-(6,7-Dihydroxy-4-methoxyisoflavan-3-yl)-2,7-dihydroxy-4-methoxyisoflavan
Cys His Gln Trp
Cys His Trp Gln
Cys Gln His Trp
Cys Gln Trp His
Cys Trp His Gln
Cys Trp Gln His
Asp Glu Phe Tyr
Asp Glu Tyr Phe
Asp Phe Glu Tyr
Asp Phe Tyr Glu
Asp Tyr Glu Phe
Asp Tyr Phe Glu
Glu Asp Phe Tyr
Glu Asp Tyr Phe
Glu Phe Asp Tyr
Glu Phe Tyr Asp
Glu Tyr Asp Phe
Glu Tyr Phe Asp
Phe Asp Glu Tyr
Phe Asp Tyr Glu
Phe Glu Asp Tyr
Phe Glu Tyr Asp
Phe Tyr Asp Glu
Phe Tyr Glu Asp
His Cys Gln Trp
His Cys Trp Gln
His Gln Cys Trp
His Gln Trp Cys
His Trp Cys Gln
His Trp Gln Cys
Gln Cys His Trp
Gln Cys Trp His
Gln His Cys Trp
Gln His Trp Cys
Gln Trp Cys His
Gln Trp His Cys
Trp Cys His Gln
Trp Cys Gln His
Trp His Cys Gln
Trp His Gln Cys
Trp Gln Cys His
Trp Gln His Cys
Tyr Asp Glu Phe
Tyr Asp Phe Glu
Tyr Glu Asp Phe
Tyr Glu Phe Asp
Tyr Phe Asp Glu
Tyr Phe Glu Asp
allylchloro[1,3-bis(2,6-di-i-propylphenyl)-4,5-dihydroimidazol-2-ylidene]palladium (ii)
4-[2-[bis(pyridin-2-ylmethyl)amino]ethylamino]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid
(4S)-3-{(2R,5R)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl)amino](4-hydroxyphenyl)methyl]-5-hydroxypentanoyl}-4-phenyl-1,3-oxazolidin-2-one
Letermovir
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals D000970 - Antineoplastic Agents > D000067856 - Poly(ADP-ribose) Polymerase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent D004791 - Enzyme Inhibitors
Carfloglitazar
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C154291 - Peroxisome Proliferator-Activated Receptor Agonist A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins
4-Quinazolineacetic acid, 8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-
sodium;(2S)-2-[[(2S)-2-[(1-ethoxycarbonylpiperidin-4-yl)oxycarbonylamino]-4-methylpentanoyl]amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonate
4-[(4-Ethoxyphenyl)sulfonylamino]-N-[(E)-(3-methyl-1-phenyl-5-pyrrolidin-1-ylpyrazol-4-yl)methylideneamino]benzamide
5-[(3R,3R,4S,5R)-4-[fluoro(dimethyl)silyl]-5-(2-hydroxyethyl)-3-methyl-2-oxo-1-prop-2-enyl-5-spiro[indole-3,2-oxolane]yl]-6-benzo[b][1,4]benzoxazepinone
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-thiazolylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-methylbenzenesulfonamide
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-thiazolylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-methylbenzenesulfonamide
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-thiazolylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-methylbenzenesulfonamide
N-[(2S,3R)-2-[[(3,5-dimethyl-4-isoxazolyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-pyrazinecarboxamide
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-thiazolylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-methylbenzenesulfonamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-thiazolylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-methylbenzenesulfonamide
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-thiazolylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-methylbenzenesulfonamide
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-thiazolylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-methylbenzenesulfonamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-thiazolylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-methylbenzenesulfonamide
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-thiazolylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-phenylmethanesulfonamide
2-[2,6-Dihydroxy-4-[6-hydroxy-7-(3-methylbut-2-enyl)-1-benzouran-2-yl]phenyl]-4-methyl-6-(2,4,5-trihydroxyphenyl)cyclohex-3-ene-1-carboxylic acid
2-[2,6-Dihydroxy-4-[6-hydroxy-7-(3-methylbut-2-enyl)-1-benzouran-2-yl]phenyl]-6-(2,4-dihydroxyphenyl)-5-hydroxy-4-methylcyclohex-3-ene-1-carboxylic acid
2-[2,6-dihydroxy-4-[6-hydroxy-7-[(E)-4-hydroxy-3-methylbut-2-enyl]-1-benzouran-2-yl]phenyl]-6-(2,4-dihydroxyphenyl)-4-methylcyclohex-3-ene-1-carboxylic acid
4-O-methylrhodomycin D(1+)
An organic cation that is the conjugate acid of 4-O-methylrhodomycin D, obtained by protonation of the amino group; major species at pH 7.3.
Chiglitazar
Chiglitazar (Carfloglitazar) is a PPARα/γ dual agonist, with EC50s of 1.2, 0.08, 1.7 μM for PPARα, PPARγ and PPARδ, respectively.
3-(3-hydroxy-2,4-dimethoxyphenyl)-4-[4-hydroxy-5-(7-hydroxy-3,4-dihydro-2h-1-benzopyran-3-yl)-2-methoxyphenyl]-3,4-dihydro-2h-1-benzopyran-7-ol
4,5,17-trihydroxy-6-(hydroxymethyl)-14,18-dimethyl-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,10-dioxapentacyclo[9.8.0.0¹,⁷.0⁴,¹⁹.0¹³,¹⁸]nonadec-14-ene-9,16-dione
4-(6',7-dihydroxy-4'-methoxyisoflavan-3'-yl)-2',7-dihydroxy-4'-methoxyisoflavan; (3r,4s,3''s)-form,3'-hydroxy,2'-me ether
{"Ingredient_id": "HBIN010058","Ingredient_name": "4-(6',7-dihydroxy-4'-methoxyisoflavan-3'-yl)-2',7-dihydroxy-4'-methoxyisoflavan; (3r,4s,3''s)-form,3'-hydroxy,2'-me ether","Alias": "NA","Ingredient_formula": "C33H32O9","Ingredient_Smile": "NA","Ingredient_weight": "572.6","OB_score": "NA","CAS_id": "100478-01-1","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7960","PubChem_id": "NA","DrugBank_id": "NA"}